Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Valsartan + Hydrochlorothiazide
- Therapeutic area
- Cardiovascular
- Drug class
- Angiotensin receptor blockers
- ATC
- C09DA
- Strength
- 25 mg + 160 mg
- Dosage form
- Tablet
- Pack
- 14’s
- Registration no.
- 082438
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (14’s). Current price PKR 573.53, effective 27 Aug 2025.
Cite this price history
MedInfoBase. C-Val Plus 25 25 mg + 160 mg, 14’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/c-val-plus-25-25-mg-160-mg-082438-14s-crystolite-pharmaceuticals/ (accessed 23 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 573.53 | 2025-08-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 082438Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
